Harvard Bioscience (HBIO) Tops Q4 EPS by 1c
Get Alerts HBIO Hot Sheet
Price: $3.84 -3.27%
EPS Growth %: -16.7%
Financial Fact:
Diluted earnings per common share: -0.05
Today's EPS Names:
MAXN, CSTR, ACU, More
EPS Growth %: -16.7%
Financial Fact:
Diluted earnings per common share: -0.05
Today's EPS Names:
MAXN, CSTR, ACU, More
Join SI Premium – FREE
Harvard Bioscience (NASDAQ: HBIO) reported Q4 EPS of $0.10, $0.01 better than the analyst estimate of $0.09. Revenue for the quarter came in at $30.4 million versus the consensus estimate of $29.3 million.
For earnings history and earnings-related data on Harvard Bioscience (HBIO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Benchmark on Take-Two's (TTWO) GTV 6 Release: 'we anticipate that the game will not be released within the fiscal year and expect it to launch in fiscal 2026 instead'
- MetroCity Bankshares, Inc. (MCBS) Tops Q1 EPS by 4c
- BancFirst Corp. (BANF) Tops Q1 EPS by 11c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!